Citius Oncology Inc.CTORNASDAQ

Revenue (LTM)

Net Income (LTM)

$-25M

-17.1% YoY

Free Cash Flow

$-5M

Revenue CAGR (5Y)

—

—Marginsstable

FCFTurned negative

Unprofitable

Metric	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Income	-10	-12↓24.8%	-21↓69.7%	-24↓14.3%
Net Income	-11	-13↓16.9%	-21↓66.6%	-25↓17.1%
EBITDA	0	-12	-21↓69.7%	-23↓14.2%
EPS Diluted	-0.08	-0.19↓149.0%	-0.30↓57.9%	-0.34↓13.3%

Metric	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	0	0	0	4↑3504282.1%
Total Current Assets	3	8↑187.5%	11↑41.8%	28↑151.1%
Total Assets	43	48↑11.8%	84↑76.7%	101↑19.6%
Total Current Liabilities	6	21↑260.0%	33↑55.4%	49↑51.3%
Total Liabilities	6	22↑245.6%	38↑72.2%	56↑46.7%
Total Equity	36	26↓29.6%	46↑80.7%	45↓2.8%
Total Debt	0	0	4	4↓0.0%
Net Debt	0	0	4	-0↓103.3%

Metric	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-0	-1↓1153.6%	0↑121.0%	-5↓4446.6%
Capital Expenditure	0	0	-0↓200.0%	-0↓0.0%
Free Cash Flow	-0	-1↓1153.5%	0↑121.0%	-5↓4446.7%
Stock-Based Comp	0	0	0	0
Net Change in Cash	0	-0↓188.7%	-0↑87.3%	4↑12127.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance